Citations (15)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
Wangqiang Hu, Xiaoxia Wang, Rongrong Yang, Laixi Bi, Yaosheng Xie, Zhuo Zhang, Hong Lu & Lianfeng Wu. (2017) Expression of CD56 is a risk factor for acute lymphocytic leukemia with central nervous system involvement in adults. Hematology 22:2, pages 81-87.
Read now
Read now
Joe Antony Jacob, Jumah Masoud Mohammad Salmani & Baoan Chen. (2016) Drugs under preclinical and clinical study for treatment of acute and chronic lymphoblastic leukemia. Patient Preference and Adherence 10, pages 1115-1119.
Read now
Read now
Yu Zhu & Si-Xuan Qian. (2014) Clinical efficacy and safety of imatinib in the management of Ph+ chronic myeloid or acute lymphoblastic leukemia in Chinese patients. OncoTargets and Therapy 7, pages 395-404.
Read now
Read now
Articles from other publishers (12)
Hideki Nakasone. (2023) Prophylactic or preemptive tyrosine kinase inhibitor therapy after allogeneic hematopoietic cell transplantation for Philadelphia chromosome-positive acute lymphoblastic leukemia. International Journal of Hematology 118:2, pages 183-192.
Crossref
Crossref
Mixue Xie, Ting Shi, Qi Jiang, Yunlu Jia, De Zhou, Hongyan Tong, Jie Jin & Hong‐Hu Zhu. (2023) Chemotherapy with the use of next‐generation tyrosine kinase inhibitors based on measurable residual disease has the potential to avoid hematopoietic stem cell transplantation in treatment for adults with Philadelphia chromosome–positive acute lymphoblastic leukemia. Cancer 129:10, pages 1523-1536.
Crossref
Crossref
Radhika Takiar, Charles E. Foucar, Anthony J. Perissinotti, Bernard L. Marini, Lydia Benitez-Colon, Patrick W. Burke & Dale L. Bixby. (2022) Real world outcomes in patients with Philadelphia chromosome positive acute lymphoblastic leukemia undergoing allogeneic stem cell transplantation–A single institution experience. Leukemia Research Reports 18, pages 100352.
Crossref
Crossref
Hui Liu, Li Xuan, Ren Lin, Lan Deng, Zhiping Fan, Danian Nie, Xudong Li, Xinquan Liang, Dan Xu, Yu Zhang, Na Xu, Jieyu Ye, Hua Jin, Dongjun Lin, Liping Ma, Jing Sun, Fen Huang & Qifa Liu. (2020) A new pre-emptive TKIs strategy for preventing relapse based on BCR/ABL monitoring for Ph+ALL undergoing allo-HCT: a prospective clinical cohort study. Leukemia 35:7, pages 2054-2063.
Crossref
Crossref
Neeraj Saini, David Marin, Celina Ledesma, Ruby Delgado, Gabriela Rondon, Uday R. Popat, Qaiser Bashir, Chitra M. Hosing, Yago Nieto, Amin M. Alousi, Muzaffar H. Qazilbash, Stefan Ciurea, Elizabeth Shpall, Issa Khouri, Hagop Kantarjian, Elias Jabbour, Farhad Ravandi, Richard E. Champlin & Partow Kebriaei. (2020) Impact of TKIs post–allogeneic hematopoietic cell transplantation in Philadelphia chromosome–positive ALL. Blood 136:15, pages 1786-1789.
Crossref
Crossref
Zabih Warraich, Pavan Tenneti, Theresa Thai, Anne Hubben, Hina Amin, Ali McBride, Sami Warraich, Abdul Hannan, Faiza Warraich, Navneet Majhail, Matt Kalaycio & Faiz Anwer. (2020) Relapse Prevention with Tyrosine Kinase Inhibitors after Allogeneic Transplantation for Philadelphia Chromosome–Positive Acute Lymphoblast Leukemia: A Systematic Review. Biology of Blood and Marrow Transplantation 26:3, pages e55-e64.
Crossref
Crossref
Satoshi Nishiwaki, Isamu Sugiura, Yasuhiko Miyata, Shigeki Saito, Masashi Sawa, Tetsuya Nishida, Koichi Miyamura, Yachiyo Kuwatsuka, Akio Kohno, Masaaki Yuge, Masanobu Kasai, Hiroatsu Iida, Shingo Kurahashi, Masahide Osaki, Tatsunori Goto, Seitaro Terakura, Makoto Murata, Hiroyoshi Nishikawa & Hitoshi Kiyoi. (2017) Efficacy and safety of autologous peripheral blood stem cell transplantation for Philadelphia chromosome-positive acute lymphoblastic leukemia. Medicine 96:52, pages e9568.
Crossref
Crossref
Hayley Rose-Inman & Damon Kuehl. (2017) Acute Leukemia. Hematology/Oncology Clinics of North America 31:6, pages 1011-1028.
Crossref
Crossref
Jean El-Cheikh, Imane El Dika, Radwan Massoud, Maya Charafeddine, Rami Mahfouz, Mohamed A. Kharfan-Dabaja & Ali Bazarbachi. (2017) Hyper-CVAD Compared With BFM-like Chemotherapy for the Treatment of Adult Acute Lymphoblastic Leukemia. A Retrospective Single-Center Analysis. Clinical Lymphoma Myeloma and Leukemia 17:3, pages 179-185.
Crossref
Crossref
S Nishiwaki, K Imai, S Mizuta, H Kanamori, K Ohashi, T Fukuda, Y Onishi, S Takahashi, N Uchida, T Eto, H Nakamae, T Yujiri, S Mori, T Nagamura-Inoue, R Suzuki, Y Atsuta & J Tanaka. (2015) Impact of MRD and TKI on allogeneic hematopoietic cell transplantation for Ph+ALL: a study from the adult ALL WG of the JSHCT. Bone Marrow Transplantation 51:1, pages 43-50.
Crossref
Crossref
Hayley Rose-Inman & Damon Kuehl. (2014) Acute Leukemia. Emergency Medicine Clinics of North America 32:3, pages 579-596.
Crossref
Crossref
Marcos de Lima, David L. Porter, Minoo Battiwalla, Michael R. Bishop, Sergio A. Giralt, Nancy M. Hardy, Nicolaus Kröger, Alan S. Wayne & Christoph Schmid. (2014) Proceedings from the National Cancer Institute’s Second International Workshop on the Biology, Prevention, and Treatment of Relapse after Hematopoietic Stem Cell Transplantation: Part III. Prevention and Treatment of Relapse after Allogeneic Transplantation. Biology of Blood and Marrow Transplantation 20:1, pages 4-13.
Crossref
Crossref